SHARE
COPY LINK

NIPH

Norway sees Covid infections fall as R rate rises

Coronavirus infections fell by 19 percent in Norway compared to two weeks ago. Despite this, the R-number or reproduction rate has risen to 1.0, according to the Norwegian Institute of Public Health’s latest report.

Norway sees Covid infections fall as R rate rises
A coronavirus test. Ben STANSALL / AFP

An R-number of one means infections remain at a stable level; this means for every ten people with Covid-19, they, on average, will infect another ten people, meaning the epidemic stays at a steady level.

The previous R-number was 0.7, which meant the virus was receding in Norway.

There was a decrease of almost 20 percent in the number of reported cases last week compared to the week before, with the exception of the week beginning May 3rd cases have fallen every week since mid-March which was the peak of Norway’s third coronavirus wave. 

According to the report, the number of reported cases fell or remained stable in every county in Norway bar Innlandet and Trøndelag.

Since the peak of the third wave, the number of positive tests being returned has fallen by more than two thirds.

For the first time since Covid-19 was first recorded in Norway, a county other than Oslo has the most infections per 100,000 residents. Vestfold and Telemark currently have the highest infection rates per 100,000 in Norway. Vestfold and Telemark recorded 240 cases per 100,000 cases.

READ ALSO: Oslo to increase the interval between Covid-19 vaccines.

Hospital admissions also decreased last week. Some 60 people were admitted to hospital last week, compared to 70 two weeks ago. Deaths have also steadily declined since the beginning of April. However, one more person died compared to two weeks ago.

The B117 strain of Covid-19, which was first detected in the United Kingdom, remains the dominant strain in Norway. Approximately 93 percent of all cases are of the B117 variant.

The B1351 coronavirus variant, which originated in South Africa, only accounts for 0.2% percent of cases meaning the chain of infection for this virus variant may have been broken in Norway.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Public Health Agency recommends two Covid doses next year for elderly

Sweden's Public Health Agency is recommending that those above the age of 80 should receive two doses of a Covid-19 vaccine a year, once in the spring and once in the autumn, as it shifts towards a longer-term strategy for the virus.

Public Health Agency recommends two Covid doses next year for elderly

In a new recommendation, the agency said that those living in elderly care centres, and those above the age of 80 should from March 1st receive two vaccinations a year, with a six month gap between doses. 

“Elderly people develop a somewhat worse immune defence after vaccination and immunity wanes faster than among young and healthy people,” the agency said. “That means that elderly people have a greater need of booster doses than younger ones. The Swedish Public Health Agency considers, based on the current knowledge, that it will be important even going into the future to have booster doses for the elderly and people in risk groups.” 

READ ALSO: 

People between the ages of 65 and 79 years old and young people with risk factors, such as obesity, diabetes, poor kidney function or high blood pressure, are recommended to take one additional dose per year.

The new vaccination recommendation, which will start to apply from March 1st next year, is only for 2023, Johanna Rubin, the investigator in the agency’s vaccination programme unit, explained. 

She said too much was still unclear about how long protection from vaccination lasted to institute a permanent programme.

“This recommendation applies to 2023. There is not really an abundance of data on how long protection lasts after a booster dose, of course, but this is what we can say for now,” she told the TT newswire. 

It was likely, however, that elderly people would end up being given an annual dose to protect them from any new variants, as has long been the case with influenza.

SHOW COMMENTS